Fourth Neurosurgery Department, Cangzhou Central Hospital, Cangzhou, Hebei Province, PR China.
Medicine (Baltimore). 2022 Dec 16;101(50):e31394. doi: 10.1097/MD.0000000000031394.
The current surgical management of adult Chiari malformation type I (CM-I) with associated syringomyelia remains controversial. The objective of this study was to explore posterior fossa decompression and duraplasty (PFDD) with and without tonsillar resection in adult patients with CM-I and syringomyelia.
A total of 116 adult patients suffering from both CM-I and syringomyelia who were scheduled to undergo surgical decompression at our institution between 2012 and 2020 were randomly divided into 2 groups: the PFDD group (n = 64) underwent PFDD without tonsillar resection, while the PFDD-T group (n = 52) underwent PFDD with tonsillar resection. The primary outcome was improvement or resolution of the syrinx. The secondary outcome was an improvement in clinical outcome based on Chicago Chiari Outcome Scale (CCOS) scores. All participants were followed-up to 1-year postoperatively.
The proportions of patients who had >20% improvement in syrinx size were 60.9% and 78.8% in the PFDD and PFDD-T groups, respectively (P = .038). The improvement in clinical outcome based on CCOS scores was significantly different in the 2 groups (P = .004). The functionality sub-score was significantly different between the 2 groups (P = .027), but there were no significant differences in the pain symptoms, non-pain symptoms, and complications sub-scores. The total CCOS scores were higher in the PFDD-T group than in the PFDD group (P = .037).
This study determined the role of tonsillar resection in achieving obvious syrinx improvement following PFDD-T. PFDD with tonsillar resection seems to be a safe and effective surgical option to treat adult CM-I patients with syringomyelia.
成人 Chiari 畸形 I 型(CM-I)伴脊髓空洞症的当前手术治疗仍存在争议。本研究旨在探讨后路减压和硬脑膜成形术(PFDD)联合和不联合扁桃体切除术治疗成人 CM-I 伴脊髓空洞症患者的效果。
2012 年至 2020 年期间,我院计划接受手术减压的 116 例成人 CM-I 伴脊髓空洞症患者被随机分为 2 组:PFDD 组(n=64)行 PFDD 不伴扁桃体切除术,PFDD-T 组(n=52)行 PFDD 伴扁桃体切除术。主要结局为空洞缩小或消失。次要结局为基于芝加哥 Chiari 结局量表(CCOS)评分的临床结局改善。所有患者均随访至术后 1 年。
空洞缩小>20%的患者比例,PFDD 组为 60.9%,PFDD-T 组为 78.8%(P=.038)。2 组患者的 CCOS 评分改善情况差异有统计学意义(P=.004)。功能子评分在 2 组间差异有统计学意义(P=.027),但疼痛症状、非疼痛症状和并发症子评分差异无统计学意义。PFDD-T 组的 CCOS 总分高于 PFDD 组(P=.037)。
本研究确定了扁桃体切除术在 PFDD-T 后明显改善空洞的作用。PFDD 联合扁桃体切除术似乎是治疗成人 CM-I 伴脊髓空洞症的一种安全有效的手术选择。